Discern the complex and sometimes difficult questions about moving your compound from preclinical to clinical development with Covance.
Access state-of-the-art clinical research units in the United States and United Kingdom, and tap into the Covance expertise that has successfully transitioned compounds from one development phase to the next after safety and efficacy questions are addressed. Use information from early development, interpreted by Covance experts, to manage the transition from nonclinical to Phase I and IIa clinical trials:
For successful Phase I-IIa candidates, draw on the broad knowledge and expertise of Covance for Phase II-III studies that encompass all aspects of planning and execution; everything from clinical trial design, scientific consultation for laboratory services and clinical trial management to regulatory submissions.
Covance is everywhere you need to be. We offer clinical development services in nearly 60 countries, including emerging markets across Asia-Pacific, Central and Eastern Europe, and Latin America. With clinical trial experts located across the world, Covance has the depth and breadth of expertise required where you need it and when you need it.